NCT06664203

Brief Summary

aim of this study is to compare the effect of selective truncal blocks, performed at different doses and volumes, on the onset times of motor and sensory blocks required for anesthesia in patients scheduled for hand, wrist, forearm, and elbow surgeries. Completing the operation under regional anesthesia will be considered a successful block.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

March 5, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

October 27, 2024

Last Update Submit

March 2, 2025

Conditions

Keywords

postoperative painselective turuncus blockarm anaesthesia

Outcome Measures

Primary Outcomes (1)

  • on the onset times of motor and sensory blocks required for anesthesia

    The primary outcome of this study is to compare the effect of selective truncal blocks, performed at different doses and volumes, on the onset times of motor and sensory blocks required for anesthesia in patients scheduled for hand, wrist, forearm, and elbow surgeries. Completing the operation under regional anesthesia will be considered a successful block.

    24 hour

Secondary Outcomes (3)

  • Total Opioid Consumption

    24 hour

  • time to first rescue analgesic requirement.

    24 hour

  • diaphragm paralysis

    24 hour

Study Arms (2)

with 15 ml SeTb group

ACTIVE COMPARATOR

This group will receive a SeTB (Selective Trunk Block) with a total of 15 ml of bupivacaine

Procedure: Selective turuncus block with 15 ml bupivacain

With 25 ml bupivacain SeTb

ACTIVE COMPARATOR

This group will receive a SeTB (Selective Trunk Block) with a total of 25 ml of bupivacaine

Procedure: Selective turuncus block with 25 ml bupivacain

Interventions

A high-frequency linear ultrasound (USG) probe will be used to locate the C7 transverse process, which will serve as a sonoanatomic landmark. Once the C5 ventral ramus is identified at the C7 transverse process level, the linear probe will be slightly caudally angled to visualize the C6 ventral ramus. The area where the superior trunk is formed by C5 and C6 will be examined with the USG probe until the superior trunk is visualized. Below the superior trunk, the middle trunk and the C8 ventral ramus will be visible. In Group 1, a total of 23 ml of 0.5% bupivacaine plus 2 ml (8 mg dexamethasone) will be used as the local anesthetic mixture, totaling 25ml. 7ml of the local anesthetic mixture will be injected into the superior trunk, the middle trunk for an additional 8 ml. The probe will then be directed caudally to obtain an optimal view of the lower trunk, where 10 ml of the same mixture will be injected close to the lower trunk.

With 25 ml bupivacain SeTb

In Group 2, 13 ml of 0.5% bupivacaine plus 2 ml (8 mg dexamethasone) will be used, totaling 15 ml. In Group 2, 5 ml of the local anesthetic mixture will be injected into the superior trunk, followed by 5 ml into the middle trunk and 5 ml into the lower trunk, as in Group II.

with 15 ml SeTb group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA 1-2
  • Body Mass Index (BMI) of 18-35 kg/m²
  • Age: 18-65 years -Patients undergoing all upper extremity orthopedic surgeries, except shoulder surgeries (distal humerus, elbow, forearm, hand, and wrist), will be included. -

You may not qualify if:

  • Patient refusal
  • Pregnancy or breastfeeding
  • Severe pulmonary disease
  • Contralateral diaphragm paralysis
  • Nerve injury secondary to trauma
  • Neuromuscular disease
  • Peripheral neuropathy
  • Bleeding diathesis
  • Allergy to local anesthetics and dexamethasone
  • Uncontrolled diabetes mellitus
  • Morbid obesity with BMI \>35
  • Severe cardiovascular, renal, or hepatic disease
  • Infection at the site of the nerve block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziosmanpasa Research and Training Hospital

Istanbul, 34255, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Sivashanmugam T, Sripriya R, John Paul S, Ravishankar M. Estimation of minimum effective local anaesthetic volume to block the lower trunk during selective truncal injection brachial plexus block. Indian J Anaesth. 2022 Aug;66(Suppl 5):S281-S283. doi: 10.4103/ija.ija_1087_21. Epub 2022 Aug 12. No abstract available.

  • Bao X, Huang J, Feng H, Qian Y, Wang Y, Zhang Q, Hu H, Wang X. Effect of local anesthetic volume (20 mL vs 30 mL ropivacaine) on electromyography of the diaphragm and pulmonary function after ultrasound-guided supraclavicular brachial plexus block: a randomized controlled trial. Reg Anesth Pain Med. 2019 Jan;44(1):69-75. doi: 10.1136/rapm-2018-000014.

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Study Officials

  • Serpil Sehirlioglu, MD

    Gaziosmanpasa Research and Training Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

serpil Sehirlioglu, MD

CONTACT

DONDU GENC MORALAR, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal invertigator

Study Record Dates

First Submitted

October 27, 2024

First Posted

October 29, 2024

Study Start

November 1, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

March 5, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

The data associated with the paper are not publicly available but are available from the corresponding author on reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
FİRST 5 YEARS
Access Criteria
drserpilsahin@gmail.com

Locations